JSM2023
Back to all people

Cong Chen

Merck & Co., Inc.
3 appearances in the program

Sessions & presentations

Contributed Poster Presentations: Biopharmaceutical Section
Presentation: 07 Assessment of Added Activity of An Antitumor Agent
Contributed Posters · Mon, Aug 7 , 10:30 AM
First Author
Recent advances and emerging challenges for expedited oncology development program
Presentation: To go or not to go in Phase 2/3, a critical question with a unified answer
Topic-Contributed Paper Session · Wed, Aug 9 , 10:30 AM
Speaker
Seamless late-stage development in oncology – the past decade in practice
Presentation: Case Study – 2-in-1 design in oncology and considerations
Topic-Contributed Paper Session · Thu, Aug 10 , 8:30 AM
Co-Author
↑